Core Insights - Despite the active performance of sectors like technology, new consumption, and pharmaceuticals, investors have found it challenging to achieve ideal returns, with the CSI 300 index showing a mere 0.03% increase year-to-date as of June, contrasting sharply with the nearly 8% rise in the Wind Active Equity Mixed Fund Index, highlighting the scarcity of professional research capabilities in volatile markets [1] Group 1: Fund Performance - In Q2, public funds achieved a total profit of 386.3 billion yuan, with Fuqun Fund ranking fifth in the industry with a profit of 19.492 billion yuan. For the first half of the year, Fuqun Fund generated 29.832 billion yuan for investors, placing it fourth overall [2] - Fuqun Fund's active equity research strength is a core competitive advantage, with 11 of its equity funds ranking in the top 10 of their categories over the past year. Notably, Fuqun Medical Innovation Stock A and Fuqun Active Growth One-Year Regular Open Mixed Fund both exceeded 40% in returns [2][3] Group 2: Long-term Performance - Over the past five and seven years, Fuqun Fund has had 5 and 10 products, respectively, ranking in the top 10 of their categories. Fuqun New Vitality Flexible Allocation Mixed A achieved returns of 67.84% and 175.32% over the past five and seven years, respectively, ranking first in its category [4] - Fuqun Global Consumer Selection A, managed by a Hong Kong fund manager, has shown impressive long-term performance with returns of 86.16% and 70.68% over the past two and three years [3] Group 3: Fixed Income and Quantitative Strategies - In the fixed income sector, Fuqun Fund's products have maintained a "steady" approach despite market challenges. Fuqun Strong Return Regular Open Bond A achieved returns of 13.03%, 23.28%, and 45.09% over three, five, and seven years, respectively, ranking in the top 9% of its category [5] - Fuqun Fund's quantitative strategies have also performed well, with 10 of its quantitative funds ranking in the top 10 of their categories over the past year. The classic broad-based ETF, the Shanghai Composite Index ETF, has consistently ranked in the top 5 over three, five, and seven years [6]

Core Viewpoint - Hangzhou Kelin (688611.SH) reported its 2024 annual results, revealing significant institutional investor interest with 26 institutions holding a total of 18.71 million shares, representing 17.07% of the total share capital [1] Group 1: Institutional Holdings - A total of 26 institutional investors disclosed their holdings in Hangzhou Kelin, with a combined shareholding of 18.71 million shares, accounting for 17.07% of the total share capital [1] - The top ten institutional investors collectively hold 16.98% of the shares, with a slight decrease of 0.01 percentage points compared to the previous quarter [1] Group 2: Public Fund Activity - Four public funds increased their holdings in this period, with an increase in shareholding proportion of 0.62% [2] - A total of 20 new public funds disclosed their holdings compared to the previous quarter, including notable funds such as 富国积极成长一年定期开放混合 and 景顺长城稳健回报混合A类 [2] - Two public funds were not disclosed in this period compared to the previous quarter, indicating a reduction in reporting [2]